Kingsbrook Jewish Medical Center

Pharmacy Residency Programs

Critical Care Pharmacotherapy (PGY-2) Residency Program

For further information please contact:

HENRY COHEN, B.S., M.S., Pharm.D., FCCM, BCPP, CGP
Chief Pharmacotherapy Officer
Director of Pharmacy Residency Programs (PGY-1 and PGY-2)
Phone: (718) 604-5373 | Fax: (718) 604-5486
Email: HCohen@kingsbrook.org

Critical Care Pharmacotherapy Residency Goals

The Kingsbrook Jewish Medical Center and the Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, offer a one-year ASHP-accredited Specialty Residency Program in Critical Care Pharmacotherapy (PGY-2). The primary goals of this residency program are to prepare the resident to become a highly-trained pharmacy professional with leadership skills, a proficient specialist in critical care pharmacotherapy, competent in publication & presentation scholarship, and clinical research & design. Upon completion of this advanced training program, the resident should be poised for careers in hospital practice, academia, or industry. The resident will receive comprehensive, intense, and individualized training in all aspects of critical care pharmacy practice from dedicated and passionate pharmacy faculty.

Pharmacotherapy Position Description

The resident will be responsible for providing comprehensive medication therapy management for critically-ill patients in the following settings: medical/surgical critical care unit, cardiac critical care unit, emergency department, and surgery units. The resident will have the opportunity to provide emergency medicine pharmacy services via the emergency medicine pharmacy satellite, and will partner with paramedics throughout New York City in hospital ambulances. Residents will be trained to provide nutritional support to the critically ill. Clerkship opportunities in Clinical Pharmacokinetics and Infectious Diseases are available.

Additionally, the resident will perform pharmacotherapy and pharmacokinetic consultations, and approve restricted antimicrobials for the critically ill. The resident will interact with several critical care pharmacy and medicine faculty. He/she will participate in adverse drug event and medication error reporting, and will perform admission histories and medication reconciliation, and drug discharge counseling. The resident will receive BCLS and ACLS training and certification, and participate in codes. Regarding academic training, an IRB-approved scholarly research project is required. Moreover, there is a faculty appointment with the Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University.

Research Project and Publishing Requirements

The resident is required to complete one rigorous scholarly critical care research project. The resident will be responsible for preparing a research proposal including justification for the project and study methodology, determination of a power analysis, application of appropriate statistical analysis, development of a budget, receiving IRB approval, collaborating with research-intensive medical residents, presenting via poster or platform presentation, and publishing the results as an abstract and manuscript.

Qualifications

To qualify for this ASHP-accredited critical care pharmacotherapy residency program (PGY-2), you must be a graduate of an ACPE-accredited college of pharmacy, possess a Pharm.D. degree, or a Post-BS Pharm.D. degree or equivalent experience, and have completed an ASHP-accredited Pharmacy Practice Residency (PGY-1). Pharmacy licensure or eligibility for licensure in NY State is required.

Click the links below for more information: